10:39 AM EST - ProMIS Neurosciences, Inc. : Will participate in several of the biotechnology industry's most well-attended annual conferences. At these events, company leadership will provide current and potential investors with an updated overview of its drug discovery and development programs for Alzheimer's, Parkinson's and ALS (amyotrophic lateral sclerosis). ProMIS Neurosciences, Inc.
shares T.PMN are trading unchanged at $0.23.
